What is Finasteride?
Finasteride is an active ingredient originally developed for treating benign prostatic enlargement and was approved by the US Food and Drug Administration (FDA) for this application in 1992. [1] Five years later, in 1997, approval for male pattern hair loss followed. [2] Today, finasteride is available in various dosages (oral and topical). This article focuses on the mechanism of action and scientific evidence for efficacy, independent of the form of administration. For a detailed comparison of different application forms, read our article on topical vs. oral finasteride.
Mechanism of Action of Finasteride Against Hair Loss
To understand how finasteride works, we must first look at the biological mechanisms of hair loss.
DHT: An Important Factor in Androgenetic Alopecia
Dihydrotestosterone (DHT) is an important factor in hereditary hair loss. Learn more about hair loss causes in our fundamentals article. DHT is formed when the enzyme 5α-reductase type II converts testosterone. [3] DHT binds more strongly to the androgen receptor than testosterone and plays a central role in androgenetic alopecia. [4]
In people with the corresponding predisposition, DHT causes the hair follicles to gradually become smaller. First, the growth phase is shortened. The hair follicles then become smaller and thinner. Strong hairs become fine vellus hairs. Eventually, the follicles stop growing completely.
Finasteride Blocks DHT Production
This is where finasteride comes in: It inhibits the enzyme 5α-reductase type II and thus prevents the conversion of testosterone to DHT. The effects are measurable: In the scalp, DHT decreases by 64 to 69%, which explains the effect on hair follicles. In the blood, DHT is reduced by about 70%. [5]
Important: Finasteride lowers DHT, not testosterone directly. Possible effects and side effects still need individual physician assessment.
Additional Positive Effects on Hair Follicles
Recent research shows that finasteride not only lowers DHT but also acts directly on hair follicles. The active ingredient protects the cells of hair follicles from dying and extends the growth phase of the hairs. [6] [7] At the same time, it activates important signaling pathways for hair growth and promotes stem cells in the hair roots. [8]
These combined effects may explain why finasteride stabilizes progression in many users and why new hair growth has also been observed in studies.
Clinical Studies and Scientific Evidence
The efficacy of finasteride has been investigated in numerous clinical studies over more than two decades.
The Most Important Study from 1998
The most important study on finasteride was published in 1998 in the Journal of the American Academy of Dermatology. [9] This study examined over 1,500 men with hereditary hair loss over two years. A total of 1,553 men between 18 and 41 years participated, who were randomly divided into a finasteride group (1 mg daily) or placebo group. The study was conducted double-blind, meaning neither participants nor doctors knew who received the real medication. The main goal was to measure hair count and hair growth.
The results after 12 months showed a distinct difference between the finasteride and placebo groups:
| Parameter | Finasteride | Placebo |
|---|---|---|
| Improvement (physician assessment) | 48% | 7% |
| No change | 42% | 25% |
| Deterioration | 10% | 68% |
After 24 months, the positive effects continued: 66% of the finasteride group showed improvement, compared with only 7% in the placebo group. Hair count continued to increase and improvements remained stable.
Long-term Study Over 5 Years
A follow-up study tracked participants over five years. [10] Results remained stable over that period, while progressive hair loss was observed in the placebo group. The study reported a markedly lower likelihood of further visible hair loss with finasteride. As with long-term data, dropout and adherence need to be considered when interpreting the results.
Lower Dosages
Studies showed that lower dosages than the standard 1 mg dose can also be effective. [11] Detailed information on various dosages (oral and topical) can be found in our article on finasteride prescriptions.
When Are First Results Visible?
The effect of finasteride is delayed and develops gradually. In the first months, hair loss may stabilize; some users notice fewer hairs falling out.
After 3 to 6 months, first visible changes may become apparent. Between months 6 and 12, studies often assess clearer changes.
After 12 to 24 months, response can usually be assessed more reliably.
Therapy with finasteride requires patience. Users should wait at least 12 months before assessing efficacy. Premature discontinuation can result in missing potential successes.
Want to stop hair loss and regrow your hair?
Get startedWhich Factors Influence Response?
The efficacy of finasteride varies depending on individual profile and stage of hair loss.
Factors Linked to Better Response
Studies show better responses especially in men at earlier stages of hair loss, with crown or vertex involvement, and where hair follicles are still active. In already bald areas, the effect is limited because hair follicles there are often already inactive.
When Does Finasteride Not Work?
Finasteride shows no or little effect in completely bald areas because hair follicles there are already inactive. Even with very advanced hair loss, success prospects are limited. For circular hair loss (alopecia areata) or other forms of non-hereditary hair loss, finasteride does not work.
Finasteride cannot reactivate already inactive hair follicles. In studies, outcomes were better when active, albeit miniaturized, hair follicles were still present.
Use in Women
Data for finasteride in women is limited. Smaller studies show evidence of efficacy in postmenopausal women at higher doses of 5 mg. [12] In premenopausal women, there is insufficient data. Additionally, there is a contraindication due to pregnancy risk.
During pregnancy, finasteride is absolutely contraindicated because there is a significant risk of malformations. In Switzerland, finasteride is not approved for women and is only used in exceptional cases in postmenopausal women.
What Happens After Discontinuation?
An important point: The effect of finasteride only persists with continuous use. After discontinuing the medication, hair loss returns within 3 to 6 months. The hair pattern develops to the level that would have been reached without treatment. Already gained hairs are lost again.
Finasteride is usually a long-term therapy. When it is effective and tolerated, treatment is often continued because the biological process of hair loss can resume without DHT blockade. Whether and how long use is appropriate should be reviewed by a physician.
Conclusion on Finasteride Efficacy
The scientific evidence for finasteride in male androgenetic alopecia is extensive. Studies show stabilization in many users and visible improvement in some. How well someone responds depends on stage, pattern, tolerability, product, and individual physician assessment.
For practical information on obtaining and using finasteride, see our articles on finasteride prescriptions and finasteride side effects. For a comparison of forms of administration, read our article on topical vs. oral finasteride. You can also start an online consultation or learn more about the causes of hair loss.
References
- [1] Zito PM, Bistas KG, Patel P, Syed K. (2024). Finasteride. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK513329/ (Accessed 25.08.2025)
- [2] American Hair Loss Association. (n.d.). Finasteride (Proscar/Propecia). American Hair Loss Association. https://www.americanhairloss.org/hair-loss-treatment/drug-therapy/finasteride/ (Accessed 26.08.2025)
- [3] Makridakis N, Reichardt JKV. (2005). Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride. Journal of Molecular Endocrinology. https://doi.org/10.1677/jme.1.01725
- [4] Deslypere JP, Young M, Wilson JD, McPhaul MJ. (1992). Testosterone and 5α-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene. Molecular and Cellular Endocrinology. https://doi.org/10.1016/0303-7207(92)90004-P
- [5] Drake L, Hordinsky M, Fiedler V, et al.. (1999). The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. Journal of the American Academy of Dermatology. https://pubmed.ncbi.nlm.nih.gov/10495374 (Accessed 29.08.2025)
- [6] Sawaya ME, Blume-Peytavi U, Mullins DL, et al.. (2002). Effects of finasteride on apoptosis and regulation of the human hair cycle. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.1007/s10227-001-0024-y
- [7] Kim JH, Na J, Bak DH, et al.. (2019). Development of finasteride polymer microspheres for systemic application in androgenic alopecia. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2019.4149
- [8] Rattanachitthawat N, Pinkhien T, Opanasopit P, Ngawhirunpat T, Chanvorachote P. (2019). Finasteride Enhances Stem Cell Signals of Human Dermal Papilla Cells. In Vivo. https://doi.org/10.21873/invivo.11592
- [9] Kaufman KD, Olsen EA, Whiting D, et al.. (1998). Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology. https://doi.org/10.1016/s0190-9622(98)70007-6
- [10] Finasteride Male Pattern Hair Loss Study Group. (2002). Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. European Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/11809594/ (Accessed 29.12.2025)
- [11] Kaufman KD, Rotonda J, Shah AK, Meehan AG. (2008). Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia. European Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/18573712/ (Accessed 29.12.2025)
- [12] Fertig RM, Caresse GA, Darwin E, Gaudi S. (2017). Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: a comprehensive review. Dermatology Online Journal. https://doi.org/10.5070/D32311037240
- [13] Oliveira-Soares R, Silva ME, Correia PM, Andre MC. (2013). Finasteride 5mg/day treatment of patterned hair loss in normo-androgenetic postmenopausal women. International Journal of Trichology. https://doi.org/10.4103/0974-7753.114709